Iskalni niz:
išči po
išči po
išči po
išči po
Vrsta gradiva:
Jezik:
Št. zadetkov: 2
Treatment with cladribine tablets beyond year 4
Mario Habek, Jelena Drulović, Gregor Brecl Jakob, Ivan Barbov, Ljiljana Radulović, Cecilia Rajda, Konrad Rejdak, Peter Turčáni
Izvirni znanstveni članek
Oznake: nevrologija;multipla skleroza;zdravljenje;
Based on the results of the pivotal CLARITY study, cladribine tablets were approved for use in the European Union in 2017 as a high-efficacy therapy for highly active relapsing-remitting multiple sclerosis (MS). Cladribine tablets are used as an induction therapy: half of the total dose is given in ...
Leto: 2023 Vir: Digitalni repozitorij raziskovalnih organizacij Slovenije
ǂA ǂmulti-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic
Anoushka P. Lal, Yi Chao Chao Foong, Paul G. Sanfilippo, Tim Spelman, Louise Rath, David Levitz, Marzena Fabis-Pedrini, Matteo Foschi, Mario Habek, Gregor Brecl Jakob
Izvirni znanstveni članek
Oznake: multiple sclerosis;covid-19;disease-modifying therapy;
Background The COVID-19 pandemic raised concern amongst clinicians that disease-modifying therapies (DMT), particularly anti-CD20 monoclonal antibodies (mAb) and fngolimod, could worsen COVID-19 in people with multiple sclerosis (pwMS). This study aimed to examine DMT prescribing trends pre- and pos ...
Leto: 2024 Vir: Digitalni repozitorij raziskovalnih organizacij Slovenije
Št. zadetkov: 2
Ključne besede:
Leto izdaje:
Avtorji:
Repozitorij:
Tipologija:
Jezik: